BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25650634)

  • 1. HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.
    Sanchez-Gaytan BL; Fay F; Lobatto ME; Tang J; Ouimet M; Kim Y; van der Staay SE; van Rijs SM; Priem B; Zhang L; Fisher EA; Moore KJ; Langer R; Fayad ZA; Mulder WJ
    Bioconjug Chem; 2015 Mar; 26(3):443-51. PubMed ID: 25650634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.
    Zhao Y; Jiang C; He J; Guo Q; Lu J; Yang Y; Zhang W; Liu J
    Bioconjug Chem; 2017 Feb; 28(2):438-448. PubMed ID: 28004910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
    Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
    J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
    Shen ZT; Zheng S; Gounis MJ; Sigalov AB
    PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting the functional complexities between high-density lipoprotein mimetics.
    Sei YJ; Ahn J; Kim T; Shin E; Santiago-Lopez AJ; Jang SS; Jeon NL; Jang YC; Kim Y
    Biomaterials; 2018 Jul; 170():58-69. PubMed ID: 29653287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies.
    Liu Y; Wu X; Mi Y; Zhang B; Gu S; Liu G; Li X
    Drug Deliv; 2017 Nov; 24(1):443-451. PubMed ID: 28165858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE
    Yin T; Li Y; Ren Y; Fuad ARM; Hu F; Du R; Wang Y; Wang G; Wang Y
    J Nanobiotechnology; 2021 Apr; 19(1):121. PubMed ID: 33910571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamically enhancing plaque targeting via a positive feedback loop using multifunctional biomimetic nanoparticles for plaque regression.
    Jiang C; Qi Z; He W; Li Z; Tang Y; Wang Y; Huang Y; Zang H; Yang H; Liu J
    J Control Release; 2019 Aug; 308():71-85. PubMed ID: 31295543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
    Narvekar M; Xue HY; Wong HL
    Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
    Patil GB; Surana SJ
    J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
    Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
    Pandita D; Kumar S; Lather V
    Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
    Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticles.
    Pradhan R; Poudel BK; Choi JY; Choi IS; Shin BS; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2015; 38(5):734-41. PubMed ID: 24824337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
    Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
    Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein mimetic nano-therapeutics targeting monocytes and macrophages for improved cardiovascular care: a comprehensive review.
    Zhen J; Li X; Yu H; Du B
    J Nanobiotechnology; 2024 May; 22(1):263. PubMed ID: 38760755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
    Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
    EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.